Anal Fistula Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The anal fistula market is segmented by Treatment Type (Surgical and Non-Surgical), Application, End-User and Geography.

Market Snapshot

Anal Fistula Treatment Market Overview
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 3.8 %
Anal Fistula Treatment Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The anal fistula treatment market will show a rapid growth due to the rising cases of inflammatory bowel diseases such as crohn’s disease and ulcerative colitis, launch of new products and growing demand of non-surgical methods such as fibrin glue injection, adipose-derived stem cells therapy.

There has been an increasing prevalence of anal fistula cases as it remains a perplexing condition for the colorectal surgeon. As per GBD 2017 Inflammatory Bowel Disease Collaborators, there were 6.8 million cases of inflammatory bowel disease IBD globally. The age-standardised prevalence rate increased from 79.5per 100000 population in 1990 to 84.3 per 100 000 population in 2017.

In addition, there is a rise in demand for safe and effective treatment with no chance of recurrence and fewer side effects that is propelling the key industry players to introduce advanced drugs and devices.

Scope of the Report

As per the scope of the report, anal fistula is a tract between the epithelial surface of the rectum and the perianal area. There are several glands in anus which sometimes get blocked or clogged. This leads to bacterial infection and results into swelling around the infected tissues. Anal fistula treatment therefore involves use of both surgical and non-surgical approaches for effective removal of anal fistulae in patients.

By Treatment Type
Non Surgical
By Application
Intersphincteric Fistula
Transsphincteric Fistula
Suprasphincteric Fistula
By End User
Ambulatory Surgical Centers
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Surgical is Expected to Dominate the Anal Fistula Treatment Market of Treatment Type Segment During the Forecast Period

The surgical treatment for an anal fistula is found to be associated with low recurrence rates, minimal incontinence and good quality of life. The best option is found to depend on the position of fistula and whether it's a single channel or branches off in different directions. Surgical procedures include fistulotomy, bioprosthetic plugs, advancement flap procedures, seton techniques, and new techniques such as LIFT and FiLaC therapy. The most common type of surgery for anal fistulas is a fistulotomy.

The surgical segment is found dominating the anal fistula treatment market due to the increasing incidences of fistula induced infections, rise in demand of safe and effective treatment helps to drive the overall market.

Anal Fistula Treatment Market Key Trends

North America is Found Leading the Anal Fistula Treatment Market

North America is found dominating the anal fistula market due to a large number of patient population with inflammatory bowel diseases, early adoption of new technologies, and high health care expenditure by the public and private sectors in the United States. There are approximately 70,000 new cases of IBD being diagnosed every year in the United States, and this high rate of IBD cases are increasing every year that has helped in the overall growth of the market. However, increasing demand for anal fistula treatment is creating opportunities and increasing awareness about the treatment in the market.

In Asia Pacific region, there is also an increased incidence of conditions such as Crohn’s disease and increased awareness about these conditions that are expected to propel the anal fistula treatment market during the forecast period.

Anal Fistula Treatment Market Growth Rate

Competitive Landscape

The presence of a considerable number of companies is found significantly contributing to market growth. Market players are actively participating in new product launches, collaboration and development to expand their market share. For instance, in February 2018, AMI has launched FiXcision instrument, which consists of the guide, circular blade, probe and base plate for the precise treatment of anal fistulas.

Key players in the anal fistula treatment market are Cook Medical, KARL STORZ SE & Co. KG, Medtronic plc, Pfizer Inc., W. L. Gore & Associates, Inc., Biolitec AG and others.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Cases of Inflammatory Bowel Diseases (IBD) Such As Crohn's Disease and Ulcerative Colitis

      2. 4.2.2 Launch of New Products

      3. 4.2.3 Growing Demand of Non-Surgical Methods Such as Fibrin Glue Injection, Adipose-derived Stem Cells Therapy

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost Associated With the Procedure

      2. 4.3.2 Lack of Awareness about Anal Fistula Treatment

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Treatment Type

      1. 5.1.1 Surgical

      2. 5.1.2 Non Surgical

    2. 5.2 By Application

      1. 5.2.1 Intersphincteric Fistula

      2. 5.2.2 Transsphincteric Fistula

      3. 5.2.3 Suprasphincteric Fistula

      4. 5.2.4 Others

    3. 5.3 By End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Ambulatory Surgical Centers

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Pfizer, Inc.

      2. 6.1.2 Cook Medical

      3. 6.1.3 KARL STORZ SE & Co. KG

      4. 6.1.4 Medtronic plc

      5. 6.1.5 AstraZeneca Plc

      6. 6.1.6 W. L. Gore & Associates, Inc (Gore Medical)

      7. 6.1.7 Biolitec AG

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Anal Fistula Treatment Market market is studied from 2018 - 2026.

The Anal Fistula Treatment Market is growing at a CAGR of 3.8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Medtronic plc, Cook Medical, Takeda Pharmaceuticals, KARL STORZ SE & Co. KG, Biolitec AG are the major companies operating in Anal Fistula Treatment Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!